SMARCA1 and cancer: Although the ARID1A–SWI/SNF complex is inactive during tumor growth, this negative association highlights the role of the ARID1A–SWI/SNF complex in cancer development through the suppression of oncogenic YAP1/TAZ activity (Kadoch and Crabtree, 2015).